Pilot Study of Tissue and Hematopoietic Stem Cell Collection for Humanized Xenograft Studies in Melanoma and Squamous Head and Neck Cancer

Trial Profile

Pilot Study of Tissue and Hematopoietic Stem Cell Collection for Humanized Xenograft Studies in Melanoma and Squamous Head and Neck Cancer

Recruiting
Phase of Trial: Phase II

Latest Information Update: 14 Jul 2017

At a glance

  • Drugs Filgrastim (Primary)
  • Indications Neutropenia
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Sep 2015 Planned End Date changed from 1 Jan 2019 to 1 Mar 2019 as reported by ClinicalTrials.gov.
    • 14 Sep 2015 Planned primary completion date changed from 1 Jan 2018 to 1 Mar 2018 as reported by ClinicalTrials.gov.
    • 09 Mar 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top